Excerpts

Large population studies have observed a significant trend toward increased mortality associated with B.1.1.7 (Alpha) ( 28 , 29 ).

Therefore, aside from the typical enhancement pattern of PVRL, we should be attentive to the abnormally hyperintensity of T2-FLAIR along the surface of the brain stem, which is also of indicative significance for the early diagnosis of this disease.

The plasmatic glucose level showed a decreasing trend in the first 4 months of therapy that stabilized in the range between 91-93 mg/L at week 52, in comparison to the mean value of 99.32 mg/L at baseline.

We calculated signature risk values using transcript-per-million (TPM)-normalized gene expression data available and observed non-significant HR 0.68 with p-value = 0.38, although an overall trend was preserved ( Figure 11G ).

Results The serum MPO-DNA, PAD4, C1q, IL-1β, IL-6 and IL-8 reach their peak at 24 hours after stroke onset and show a decreasing trend during acute phase.

Compared to sham-LPS rats, there was a decreasing trend in IL-10 expression in CBDL-LPS rats, but without significant difference.

In contrast, PFS showed a nonsignificant trend toward poorer outcomes in patients with ≥20% of infusions after 16:30 in the unmatched cohort (median PFS: 5.0 months, 95% CI: 4.5–9.4) compared to those with <20% (median PFS: 9.4 months, 95% CI: 7.9–10.7) (HR: 1.62, 95% CI: 1.00–2.62, p = 0.052, Figure 5 ).

In the subgroup of patients receiving first-line ICI plus chemotherapy, later ICI infusion showed a trend toward poorer PFS, but this did not reach statistical significance, potentially due to the relatively small sample size of this subgroup.

HA-PA-GEM formulations showed a trend toward lesser HI titers than similar the WIV vaccine after the third immunization ( Figure 5F ).

Additionally, the T-helper (TH) cell population displayed a positive trend, indicating successful activation.

Patients who participated in pre-habilitation showed a trend toward either improving their frailty status or maintaining their fit condition before transplantation.

Four modules were found to have a highly significant correlation with the basal/squamous subtype (yellow module: r = − 0.44; grey module: r = − 0.42; black module: r = 0.51; turquoise module: r = 0.54) ( Supplementary Figure S2E ).

Because the reported number of HA20 patients with CNS symptom is small, it is difficult to determine a clear trend.

In total, six modules were identified, with almost every module showing a highly significant correlation with clinical pathological features.

At the CD4SP stage, we found barely significant NCE enhancer function in the murine EL-4 CD4SP lymphoma cell line with the NCE1F, but not with the NCE1Fx2, even though the proximal enhancer was still functional ( Figure 2C ), indicating that NCE’s canonical enhancer function may diminish in mature CD4SP T cells.

The IVIG group showed a trend toward better Barthel Index scores without statistical significance.

Notably, the same study revealed an increase in B lymphocytes, but statistical analysis was marginally non-significant ( 139 ).

Subsequently, the average number of citations showed a trend of increasing and then decreasing, with the total number of citations peaking in 2018, reflecting a very active year in the field.

With regard to a potential effect of PD-1 blockade on the CXCR3/CXCL9 axis, we found that macrophages from tumors of GPR55 KO mice expressed significantly more CXCL9 than those from tumors of their WT counterparts, while noticing a strong trend in the same direction for monocytes ( Figure 6F ).

The intensity at the control line “C” in the cassettes may be significant weaker in samples with high FHAA titers.

Alterations in this gene can disrupt proper protein folding and membrane localization, impairing its function as a transmembrane receptor, which may be significant in the context of cancer ( 23 , 24 ).

Overall, we observed an increasing trend in annual publications over the analyzed period.

Our study confirmed a significant trend of correlation between IFI30 and TMB, MSI, and this correlation exhibited consistency with the prognostic analysis of IFI30, suggesting that in-depth consideration of immune markers is an equally critical factor influencing future immunotherapy decisions.

Compared to stable KTR, those who developed a rejection during the follow-up period showed a trend towards an increased proportion of CM Tregs within the total Treg pool independent of age ( Figure 1B ).

DPP4 and PARP11 revealed the decreasing tendency in malignant samples, with approximately significant P values ( Supplementary Figure S5C ).